International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Saved in:
| Title: | International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. |
|---|---|
| Authors: | Dacic S; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: sanja.dacic@yale.edu., Travis W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Redman M; Fred Hutchinson Cancer Center, Seattle, Washington., Saqi A; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York., Cooper WA; Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Health and Medicine, University of Sydney, Sydney, Australia; Faculty of Medicine, University of Western Sydney, Sydney, Australia., Borczuk A; Department of Anatomic/Clinical Pathology, Northwell Health, Greenvale, New York., Chung JH; Department of Pathology and Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Glass C; Department of Pathology, Duke University School of Medicine, Durham, North Carolina., Lopez JM; Department of Pathology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Sholl L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Posadas J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Walker A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhu H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wijeratne MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Connolly C; International Association for the Study of Lung Cancer, Denver, Colorado., Wynes M; International Association for the Study of Lung Cancer, Denver, Colorado., Bota-Rabassedas N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sanchez-Espiridion B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Berezowska S; Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Chou TY; Taipei Veterans General Hospital, Taipei, Taiwan., Kerr K; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, United Kingdom., Nicholson A; Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Poleri C; Independent Consultant in Thoracic Pathology, Buenos Aires, Argentina., Schalper KA; Department of Pathology and Medicine, Yale School of Medicine, New Haven, Connecticut., Tsao MS; Department of Pathology, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Carbone DP; Comprehensive Cancer Center, Division of Medical Oncology, The Ohio State University, Columbus, USA., Ready N; Department of Medicine, Duke Medical Center, Durham, North Carolina., Cascone T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heymach J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sepesi B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shu C; Division of Hematology and Oncology, Columbia University Medical Center, New York, New York., Rizvi N; Division of Hematology and Oncology, Columbia University Medical Center, New York, New York., Sonett J; Thoracic Surgery Department, Columbia University New York-Presbyterian Hospital, New York, New York., Altorki N; Department of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York, New York., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Bunn PA Jr; Medical Oncology, Colorado University School of Medicine, Aurora, Colorado., Kris MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York., Belani CP; Penn State Hershey Medical Center, Penn State Cancer Institute, Hershey, Pennsylvania., Kelly K; International Association for the Study of Lung Cancer, Denver, Colorado., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
| Corporate Authors: | IASLC Pathology Committee |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Oct; Vol. 18 (10), pp. 1290-1302. Date of Electronic Publication: 2023 Sep 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
